Cover Image
市場調查報告書

印度的醫藥品產業:2015∼2020年

Pharmaceuticals Industry in India 2015-2020

出版商 NOVONOUS 商品編碼 338550
出版日期 內容資訊 英文 298 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
印度的醫藥品產業:2015∼2020年 Pharmaceuticals Industry in India 2015-2020
出版日期: 2015年08月19日 內容資訊: 英文 298 Pages
簡介

印度的醫藥品市場,由於高齡化和人口增加、所得的增加、新的症狀和疾病的登場等,預計到2020年以年複合成長率18%擴大。印度的醫藥品產業正處於重大變革之中,為了做出全球通用的醫藥品必須改善製造業務滿足嚴格的標準。還有學名藥的組合佔市場70%以上,印度的醫藥品市場非常被細分化。過去10年進行反復的收購合併,市場整體朝整合發展。

本報告提供印度的醫藥品產業相關的詳細調查、至2020年的成長預測、市場上競爭趨勢、SWOT分析、未來趨勢與機會、策略性建議等彙整資料。

第1章 摘要整理

第2章 簡介

第3章 印度的醫藥品產業的需求

  • 印度的人口
  • 景氣變動
  • 藥物安全性

第4章 印度的醫藥品產業相關市場區隔與預測

  • 醫藥品製造
  • 醫療設備、設備製造
  • 服務
  • 包裝
  • 零售
  • 整體預測

第5章 印度的醫藥品市場上EXIM方案

  • 醫藥品出口方案
  • 醫藥品進口方案
  • 醫療設備出口方案
  • 醫療設備進口方案

第6章 印度的醫藥品產業的成長促進因素與阻礙因素

第7章 印度的醫藥品產業相關政策

第8章 印度的醫藥品產業相關風險

  • 信用風險
  • 政策風險
  • 技術性風險

第9章 印度的醫藥品產業相關產業團體

第10章 印度的醫藥品產業相關政府機關

第11章 印度的醫藥品產業的主要企業簡介

  • 醫藥品製造商
  • 醫療設備廠商
  • 醫藥品零售業者
  • 醫藥品研究開發機關

第12章 印度的醫藥品產業的競爭環境

第13章 印度的醫藥品產業分析

第14章 印度的醫藥品產業的現狀及未來趨勢

第15章 策略性建議

  • 對終端用戶
  • 對醫藥品廠商
  • 對政策決策者

圖表

目錄
Product Code: NOV0815001

Indian pharmaceuticals market is expected to grow at a CAGR of 18% by 2020 driven by the aging and growing population, rising income levels, emerging medical conditions and new diseases.

“Pharmaceuticals Industry in India is expected to be worth US$ 55.39 billion by 2020.”

The Indian Pharmaceutical Industry is in middle of big changes and not only the Industry is expected to accommodate Demographic, Epidemiological, and economic shifts in the world, but also has to upgrade manufacturing practices and match rigid standards from time to time in order to produce world-class medicines. Also, the pharmaceutical manufacturers are expected to embrace newer methods and effective practices - right from the ways drugs are discovered, then on manufacturing and packaging fronts, and to the ways drugs are made available to consumers.

The generics portfolio dominates the Indian Pharma Industry which accounts for over 70% of the market. The Indian Pharma market is largely fragmented. With a string of Mergers and Acquisitions within the market in the last decade, consolidation of the overall market has been the key Industry feature.

India's Pharmaceutical sector accounts for nearly 1.4% of the global pharmaceutical industry in terms of value 10% in terms of volume.

As per NOVONOUS estimates, pharmaceuticals manufacturing industry in India is expected to grow at a CAGR of 19.76% till 2020. Despite slowing growth in developed markets, players in generics are expected to perform reasonably well due to significant numbers of exclusivity losses and patent expirations on leading drugs in the upcoming years.

Medical devices manufacturing industry in India is expected to grow at a CAGR of 15% till 2020. Indian Medical Devices and Equipment industry is an import-led market and about 70%-80% of finished goods and related components are sourced from foreign countries. This trend is expected to continue till 2020.

Indian medical transcription Industry is expected to grow at a CAGR of 4.16% till 2020 found this study. The Pharma service predominantly includes Medical Transcription, Telemedicine, Clinical Trials, Clinical Data Management and Teleradiology amongst the others.

Private sector telemedicine industry in India is expected to grow at a CAGR of 12.35% till 2020.

On the other hand, Pharmaceuticals packaging industry in India is expected to grow at a CAGR of 5.46% till 2020.

NOVONOUS estimates that pharmaceuticals retail industry in India will grow at a CAGR of 5% in the next 5 years, which will be mainly driven by increased penetration of organized Pharma retail chains like Apollo Pharmacy, MedPlus etc.

The report also has detailed company profiles including their position in pharmaceuticals industry value chain, financial performance analysis, product and service wise business strategy, SWOT analysis and key customer details for sixteen key players in Indian market namely Abbott India, Biocon Limited, CIPLA Limited, Dr. Reddy's Laboratories, Sun Pharmaceuticals Limited, Lupin Limited, Aurobindo Pharma Limited, Torrent Pharmaceuticals Limited, Divis Laboratories Limited, IPCA Laboratories Limited, Beacton Dickinson & Company Limited, Poly Medicure Limited, Novartis India Limited, Apollo Pharmacy, MedPlus Health Services Pvt. Ltd. and National Institute of Pharmaceutical Education and Research (NIPER).

Scope of the Report:

  • This report provides a detailed view of Indian pharmaceuticals market with current available capacity and options.
  • This report identifies the need for focusing on pharmaceuticals sector in India.
  • This report provides detailed information on growth forecasts for overall pharmaceuticals industry in India up to 2020.
  • This report provides detailed information on growth forecasts for pharmaceuticals manufacturing industry in India up to 2020.
  • This report provides detailed information on growth forecasts for pharma services industry in India up to 2020.
  • This report provides detailed information on growth forecasts for pharmaceuticals packaging industry in India up to 2020.
  • This report provides detailed information on growth forecasts for pharmaceuticals retail industry in India up to 2020.
  • The report identifies the growth drivers and inhibitors for pharmaceuticals manufacturing, medical devices manufacturing, pharmaceuticals services, pharmaceuticals packaging and pharmaceuticals retail and pharmaceuticals R&D industry in India.
  • This study also identifies policies related to pharmaceuticals market in India for various sectors.
  • The report identifies various credit, policy and technical risks associated with pharmaceuticals manufacturing, medical devices manufacturing, pharmaceuticals services, pharmaceuticals packaging, pharmaceuticals retail, and pharmaceuticals R&D industry in India.
  • The report identifies EXIM scenario for pharmaceuticals products and medical devices market in India.
  • The report identifies top countries exporting pharmaceuticals products and medical devices to India.
  • The report identifies top countries importing pharmaceuticals products and medical devices from India.
  • This report has detailed profiles 16 key players in Indian pharmaceuticals market covering their value chain analysis, business strategy, financial performance, future forecasts and SWOT analysis.
  • This report covers in details the competitive landscape in Indian pharmaceuticals market.
  • This report identifies key industry bodies and associations and their role in Indian pharmaceuticals market.
  • This report identifies key government bodies and their role in Indian pharmaceuticals market.
  • This report provides PESTLE (political, economic, social, technological, legal and environmental) analysis for Indian pharmaceuticals market.
  • This report provides Porter's Five Forces analysis for pharmaceuticals manufacturing, medical devices manufacturing, pharmaceuticals services, pharmaceuticals packaging and pharmaceuticals retail and pharmaceuticals R&D industry in India.
  • This report provides SWOT (strengths, weakness, opportunities and threats) analysis for pharmaceuticals manufacturing, medical devices manufacturing, pharmaceuticals services, pharmaceuticals packaging and pharmaceuticals retail and pharmaceuticals R&D industry in India.
  • This report provides future trends and opportunities for pharmaceuticals market in India.
  • This report also provides strategic recommendations for policy makers, pharmaceuticals manufacturers and end users.

Companies covered:

Pharma Manufacturers

  • 1. Abbott India
  • 2. Biocon Limited
  • 3. CIPLA Limited
  • 4. Dr. Reddy's Laboratories
  • 5. Sun Pharmaceuticals Limited
  • 6. Lupin Limited
  • 7. Aurobindo Pharma Limited
  • 8. Torrent Pharmaceuticals Limited
  • 9. Divis Laboratories Limited
  • 10. IPCA Laboratories Limited

Medical Devices Manufacturers

  • 1. Beacton Dickinson & Company Limited
  • 2. Poly Medicure Limited
  • 3. Novartis India Limited

Pharma Retailers

  • 1. Apollo Pharmacy
  • 2. MedPlus Health Services Pvt. Ltd.

Pharma R&D Institutes

  • 1. National Institute of Pharmaceutical Education and Research (NIPER)

Table of Contents

1. Executive Summary

  • Scope of the Pharmaceutical Industry in India 2015 - 2020 Report
  • Research Methodology

2. Introduction - Pharma Industry in India

  • 2.1. Pharma Manufacturing Industry in India
    • 2.1.1. Pharma Manufacturing Industry Value Chain
  • 2.2. Medical Device Manufacturing Industry in India
    • 2.2.1. Medical Device Manufacturing Industry Value Chain
  • 2.3. Pharma Services Industry in India
    • 2.3.1. Telemedicine
      • 2.3.1.1. Telemedicine Industry Value Chain
    • 2.3.2. Teleradiology
      • 2.3.2.1. Teleradiology Industry Value Chain
    • 2.3.3. Homecare Healthcare Services
      • 2.3.3.1. Homecare Services Industry Value Chain
    • 2.3.4. Medical Transcription
      • 2.3.4.1. Medical Transcription Industry Value Chain
    • 2.3.5. Clinical Trial and Drug Testing
      • 2.3.5.1. Clinical Trial and Drug Testing Industry Value Chain
  • 2.4. Pharma Packaging Industry in India
    • 2.4.1. Pharma Packaging Value Chain
  • 2.5. Pharma Retail Industry in India
    • 2.5.1. Pharma Retail Industry Value Chain
  • 2.6. Pharma R&D Industry in India
    • 2.6.1. Pharma R&D Industry Value Chain

3. Need for Pharmaceuticals Industry in India

  • 3.1. Large Population of India
  • 3.2. Economic viability
  • 3.3. Drug Security

4. Market Segments & Forecast for Pharmaceuticals Industry in India

  • 4.1. Forecasts for Indian Pharma Manufacturing Industry 2015-2020
  • 4.2. Forecasts for Indian Medical Device & Equipment Manufacturing Industry 2015-2020
  • 4.3. Forecasts for Indian Pharma Services Industry 2015-2020
  • 4.4. Forecasts for Indian Pharma Packaging Industry 2015-2020
  • 4.5. Forecast for Pharma Retail Industry in India 2015-2020
  • 4.6. Overall Forecast for Pharmaceuticals Industry in India 2015-2020

5. EXIM Scenario in Indian Pharmaceuticals Market

  • 5.1. Export Scenario of Indian Pharmaceutical Products Market
    • 5.1.1. Value of Pharmaceutical Products Exports from India 2003-04 to 2013-14 in US$ million
    • 5.1.2. Volume of Pharmaceutical Products Exports from India 2003-04 to 2013-14 in Thousands Kg
    • 5.1.3. Top 5 Nations Importing Indian Pharmaceutical Products
  • 5.2. Import Scenario of Indian Pharmaceutical Products Market
    • 5.2.1. Value of Pharmaceutical Products Imports in India 2003-04 to 2013-14 in US$ million
    • 5.2.2. Volume of Pharmaceutical Products Imports in India 2003-04 to 2013-14 in Thousands Kg
    • 5.2.3. Top 5 Nations Exporting Pharmaceutical Products to India
  • 5.3. Export Scenario of Indian Medical Devices Market
    • 5.3.1. Value of Medical Devices Exports from India 2003-04 to 2013-14 in US$ million
    • 5.3.2. Volume of Medical Devices Exports from India 2003-04 to 2013-14
    • 5.3.3. Top 5 Nations Importing Indian Medical Devices
  • 5.4. Import Scenario of Indian Medical Devices Market
    • 5.4.1. Value of Medical Devices Imports in India 2003-04 to 2013-14 in US$ million
    • 5.4.2. Volume of Medical Devices Imports in India 2003-04 to 2013-14
    • 5.4.3. Top 5 Nations Exporting Medical Devices to India

6. Growth Drivers and Inhibitors for Pharmaceuticals Industry in India

  • 6.1. Indian Pharma Manufacturing Industry: Growth Drivers & Inhibitors
    • 6.1.1. Growth Drivers for Pharmaceuticals Manufacturing Industry in India
    • 6.1.2. Growth Inhibitors for Pharmaceuticals Manufacturing Industry in India
  • 6.2. Indian Medical Device Manufacturing Industry: Growth Drivers & Inhibitors
    • 6.2.1. Growth Drivers for Medical Device Manufacturing Industry in India
    • 6.2.2. Growth Inhibitors for Medical Device Manufacturing Industry in India
  • 6.3. Indian Pharma Services Industry: Growth Drivers & Inhibitors
    • 6.3.1. Growth Drivers for Pharmaceuticals Services Industry in India
    • 6.3.2. Growth Inhibitors for Pharmaceuticals Services Industry in India
  • 6.4. Indian Pharmaceuticals Packaging Industry: Growth Drivers & Inhibitors
    • 6.4.1. Growth Drivers for Pharmaceuticals Packaging Industry in India
    • 6.4.2. Growth Inhibitors for Pharmaceuticals Packaging Industry in India
  • 6.5. Indian Pharmaceuticals Retail Industry: Growth Drivers & Inhibitors
    • 6.5.1. Growth Drivers for Pharmaceuticals Retail Industry in India
    • 6.5.2. Growth Inhibitors for Pharmaceuticals Retail Industry in India
  • 6.6. Indian Pharmaceuticals R&D Industry: Growth Drivers & Inhibitors
    • 6.6.1. Growth Drivers for Pharmaceuticals R&D Industry in India
    • 6.6.2. Growth Inhibitors for Pharmaceuticals R&D Industry in India

7. Policies Related to Pharmaceuticals Industry in India.

  • 7.1. Central Government Policies
    • 7.1.1. Essential Commodities Act 1955
    • 7.1.2. Drugs and Cosmetics Act 1940(As amended in June 2005)
    • 7.1.3. National Pharmaceutical Pricing Policy 2012
    • 7.1.4. Drug Price Control Orders (DPCO)
    • 7.1.5. Drug Policy 1986
    • 7.1.6. Pharmaceutical Policy - 2002
  • 7.2. Guidelines related to Clinical Trial in India
  • 7.3. Guidelines related to Marketing in Indian Pharmaceuticals Industry

8. Risks Associated with Pharmaceutical Industry in India

  • 8.1. Credit Risk
    • 8.1.1. Credit Risks Associated with Indian Pharmaceuticals Manufacturing Industry
    • 8.1.2. Credit Risks Associated with Indian Medical Device Manufacturing Industry
    • 8.1.3. Credit Risks Associated with Indian Pharmaceuticals Services Industry
    • 8.1.4. Credit Risks Associated with Indian Pharmaceuticals Packaging Industry
    • 8.1.5. Credit Risks Associated with Indian Pharmaceuticals Retail Industry
    • 8.1.6. Credit Risks Associated with Indian Pharmaceuticals R&D Industry
  • 8.2. Policy Risk
    • 8.2.1. Policy Risks Associated with Indian Pharmaceuticals Manufacturing Industry
    • 8.2.2. Policy Risks Associated with Indian Medical Device Manufacturing Industry
    • 8.2.3. Policy Risks Associated with Indian Pharmaceuticals Packaging Industry
    • 8.2.4. Policy Risks Associated with Indian Pharmaceuticals Services Industry
    • 8.2.5. Policy Risks Associated with Indian Pharmaceuticals Retail Industry
    • 8.2.6. Policy Risks Associated with Indian Pharmaceuticals R&D Industry
  • 8.3. Technical Risk
    • 8.3.1. Technical Risks Associated with Indian Pharmaceuticals Manufacturing Industry
    • 8.3.2. Technical Risks Associated with Indian Medical Device Manufacturing Industry
    • 8.3.3. Technical Risks Associated with Indian Pharmaceuticals Services Industry
    • 8.3.4. Technical Risks Associated with Indian Pharmaceuticals Packaging Industry
    • 8.3.5. Technical Risks Associated with Indian Pharmaceuticals Retail Industry
    • 8.3.6. Technical Risks Associated with Indian Pharmaceuticals R&D Industry

9. Industry Associations Related to Indian Pharmaceuticals Industry

  • 9.1. Indian Drug Manufacturers' Association (IDMA)
  • 9.2. Indian Pharma Machinery Manufacturers Association (IPMMA)
  • 9.3. Indian Pharmaceutical Association (IPA)
  • 9.4. Organisation of Pharmaceutical Producers of India (OPPI)
  • 9.5. Association of Indian Medical Device Industry (AIMED)

10. Government Bodies Related to Indian Pharmaceuticals Industry

  • 10.1. Department of Pharmaceuticals
  • 10.2. Ministry of Chemicals & Fertilizers
    • The Department of Fertilizers (DOF)
  • 10.3. National Pharmaceutical Pricing Authority (NPPA)

11. Profile of Key Players in India Pharmaceuticals Industry

  • Pharma Manufacturers
  • 11.1. Abbott India Limited
    • 11.1.1. Company Profile
    • 11.1.2. Abbott India in Pharma Manufacturing Value Chain
    • 11.1.3. Abbott India: Financial Performance
    • 11.1.4. Abbott India: Business Strategy
      • 11.1.4.1. Product Level Strategy
    • 11.1.5. SWOT Analysis of Abbott India
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
    • 11.1.6. Key Customers of Abbott India
  • 11.2. Biocon Limited
    • 11.2.1. Company Profile
    • 11.2.2. Biocon Limited in Pharmaceutical Manufacturing Value Chain
    • 11.2.3. Biocon Limited: Financial Performance
    • 11.2.4. Biocon Limited: Business Strategy
      • 11.2.4.1. Product Level Business Strategy
      • 11.2.4.2. Service Level Business Strategy
    • 11.2.5. SWOT Analysis of Biocon Limited
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
    • 11.2.6. Key Customers of Biocon Limited
  • 11.3. CIPLA Limited
    • 11.3.1. Company Profile
    • 11.3.2. CIPLA Limited in Pharmaceutical Manufacturing Value Chain
    • 11.3.3. CIPLA Limited: Financial Performance
    • 11.3.4. CIPLA Limited: Business Strategy
      • 11.3.4.1. Product Level Business Strategy
      • 11.3.4.2. Service Level Business Strategy
    • 11.3.5. SWOT Analysis of CIPLA Limited
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
    • 11.3.6. Key Customers of CIPLA Limited
  • 11.4. Dr. Reddy's Laboratories
    • 11.4.1. Company Profile
    • 11.4.2. Dr. Reddy's Laboratories in Pharma Manufacturing Value Chain
    • 11.4.3. Dr. Reddy's Laboratories: Financial Performance
    • 11.4.4. Dr. Reddy's Laboratories: Business Strategy
      • 11.4.4.1. Product Level Business Strategy
      • 11.4.4.2. Service Level Business Strategy
    • 11.4.5. SWOT Analysis of Dr. Reddy's Laboratories
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
  • 11.5. Sun Pharmaceuticals Limited
    • 11.5.1. Company Profile
    • 11.5.2. Sun Pharmaceuticals Limited in Pharma Manufacturing Value Chain
    • 11.5.3. Sun Pharmaceuticals Limited: Financial Performance
    • 11.5.4. Sun Pharmaceuticals Limited: Business Strategy
    • 11.5.5. SWOT Analysis of Sun Pharmaceuticals Limited
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
    • 11.5.6. Key customers of Sun Pharmaceuticals Limited
  • 11.6. Lupin Limited
    • 11.6.1. Company Profile
    • 11.6.2. Lupin Limited in Pharma Manufacturing Value Chain
    • 11.6.3. Lupin Limited: Financial Performance
    • 11.6.4. Lupin Limited: Business Strategy
      • 11.6.4.1. Product Level Strategy
    • 11.6.5. SWOT Analysis of Lupin Limited
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
  • 11.7. Aurobindo Pharma Limited
    • 11.7.1. Company Profile
    • 11.7.2. Aurobindo Pharmaceuticals in Pharma Manufacturing Value Chain
    • 11.7.3. Aurobindo Pharmaceuticals: Financial Performance
    • 11.7.4. Aurobindo Pharmaceuticals: Business Strategy
    • 11.7.5. SWOT Analysis of Aurobindo Pharmaceuticals
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
  • 11.8. Torrent Pharmaceuticals Limited
    • 11.8.1. Company Profile
    • 11.8.2. Torrent Pharmaceuticals in Pharma Manufacturing Value Chain
    • 11.8.3. Torrent Pharmaceuticals: Financial Performance
    • 11.8.4. Torrent Pharmaceuticals: Business Strategy
    • 11.8.5. SWOT Analysis of Torrent PharmaceuticalsLimitied
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
    • 11.8.6. Key Customers of Torrent Pharmaceuticals
  • 11.9. Divis Laboratories Limited
    • 11.9.1. Company Profile
    • 11.9.2. Divis Laboratories Limited in Pharma Manufacturing Value Chain
    • 11.9.3. Divis Laboratories: Financial Performance
    • 11.9.4. Divis Laboratories: Business Strategy
    • 11.9.5. SWOT Analysis of Divis Laboratories Limtied
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
  • 11.10. IPCA Laboratories Limited
    • 11.10.1. Company Profile
    • 11.10.2. IPCA Laboratories Limited in Pharmaceutical Manufacturing Value Chain
    • 11.10.3. IPCA Laboratories Limited: Financial Performance
    • 11.10.4. IPCA Laboratories Limited: Business Strategy
    • 11.10.5. SWOT Analysis of IPCA Laboratories Limited
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
    • 11.1.10.6. Key Customers of IPCA Laboratories Limited
      • Medical Devices Manufacturers
  • 11.11. Beacton Dickinson & Company Limited
    • 11.11.1. Company Profile
    • 11.11.2. Beacton Dickinson & Company (India) in Medical Devices Manufacturing Value Chain
    • 11.11.3. Beacton Dickinson & Company (India): Financial Performance
    • 11.11.4. Beacton Dickinson & Company (India): Business Strategy
    • 11.11.5. SWOT Analysis of Beacton Dickinson & Company Limited
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
  • 11.12. Poly Medicure Limited
    • 11.12.1. Company Profile
    • 11.12.2. Poly Medicure Limited in Medical Devices Manufacturing Value Chain
    • 11.12.3. Poly Medicure (India): Financial Performance
    • 11.12.4. Polymedicure India: Business Strategy
      • 11.12.4.1. Product Level Strategy
    • 11.12.5. SWOT Analysis of Polymedicure (India)
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
  • 11.13. Novartis India Limited
    • 11.13.1. Company Profile
    • 11.13.2. Novartis India Limited in Medical Devices Manufacturing Value Chain
    • 11.13.3. Novartis India Limited: Financial Performance
    • 11.13.4. Novartis India Limited: Business Strategy
    • 11.13.5. SWOT Analysis of Novartis India Limited
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
      • Pharma Retailers in India
  • 11.14. Apollo Pharmacy
    • 11.14.1. Company Profile
    • 11.14.2. Apollo Pharmacy in Pharma Retail Value Chain
    • 11.14.3. Apollo Pharmacy: Business Strategy
    • 11.14.4. SWOT Analysis of Apollo Pharmacy
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
  • 11.15. MedPlus Health Services Pvt. Ltd.
    • 11.15.1. Company Profile 232
    • 11.15.2. MedPlus Pharmacy Limited in Pharma Retail Value Chain
    • 11.15.3. MedPlus Health Services Pvt. Ltd.: Business Strategy
    • 11.15.4. SWOT Analysis of MedPlus Health Services Pvt. Ltd.
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
      • Pharma R&D Institutes
  • 11.16. National Institute of Pharmaceutical Education and Research - NIPER
    • 11.16.1. Institution Profile
    • 11.16.2. NIPER Research and Development Value Chain
    • 11.16.3. NIPER: Financial Performance
    • 11.16.4. NIPER: Strategy
    • 11.16.5. SWOT Analysis of NIPER
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats

12. Competitive Landscape in Pharmaceuticals Industry in India

13. Analysis of Indian Pharmaceutical Industry

  • 13.1. Analysis Models for Indian Pharmaceutical Industry
    • 13.1.1. PESTEL Analysis of Pharmaceuticals Industry in India
    • 13.1.2. SWOT Analysis of Pharmaceuticals Industry in India
    • 13.1.3. Porter's Five Forces Analysis of Pharmaceuticals Industry in India
  • 13.2. Analysis Models - Indian Pharmaceuticals Manufacturing Industry
    • 13.2.1. SWOT Analysis of Indian Pharmaceuticals Manufacturing Industry
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
    • 13.2.2. Porter's Five Forces Analysis of Indian Pharmaceuticals Manufacturing Industry
  • 13.3. Analysis Models - Indian Medical Device Manufacturing Industry
    • 13.3.1. SWOT Analysis of Indian Medical Device Manufacturing Industry
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
    • 13.3.2. Porter's Five Forces Analysis of Indian Medical Device Manufacturing Industry
  • 13.4. Analysis Models - Indian Pharmaceuticals Services Industry
    • 13.4.1. SWOT Analysis of Indian Pharmaceuticals Services Industry
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
    • 13.4.2. Porter's Five Forces Analysis of Indian Pharmaceuticals Services Industry
  • 13.5. Analysis Models - Indian Pharmaceuticals Packaging Industry
    • 13.5.1. SWOT Analysis of Indian Pharmaceuticals Packaging Industry
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
    • 13.5.2. Porter's Five Forces Analysis of Indian Pharmaceuticals Packaging Industry
  • 13.6. Analysis Models - Indian Pharmaceuticals Retail Industry
    • 13.6.1. SWOT Analysis of Indian Pharmaceuticals Retail Industry
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
    • 13.6.2. Porter's Five Forces Analysis of Indian Pharmaceuticals Retail Industry
  • 13.7. Analysis Models - Indian Pharmaceuticals R&D Industry
    • 13.7.1. SWOT Analysis of Indian Pharmaceuticals R&D Industry
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
    • 13.7.2. Porter's Five Forces Analysis of Indian Pharmaceuticals R&D Industry

14. Current & Future Trends in Pharmaceuticals Industry in India

15. Strategic Recommendations

  • 15.1. Recommendations for End Users
  • 15.2. Recommendations for Pharmaceuticals Manufacturers
  • 15.3. Recommendations for Policy Makers
  • List of Exhibits
  • Notes
  • Company Information

List of Exhibits

  • Exhibit 1.1: Market Size of the Indian Pharma Industry in USD billion (2013-2020)
  • Exhibit 2.1: Healthcare spending as % of GDP in populous countries - 2012
  • Exhibit 2.2: Pharma Manufacturing Industry Value Chain
  • Exhibit 2.3: Classification of the Medical Device Industry in India
  • Exhibit 2.4: Indian Medical equipment market 2009-2014
  • Exhibit 2.5: Indian Medical devices & equipment Value chain
  • Exhibit 2.6: Telemedicine Industry Value chain
  • Exhibit 2.7: Teleradiology Industry Value chain
  • Exhibit 2.8: Homecare Services Industry Value Chain
  • Exhibit 2.9: Medical Transcription Industry Value Chain
  • Exhibit 2.10: Value Chain for Clinical trials in India
  • Exhibit 2.11: Pharma Packaging Value Chain
  • Exhibit 2.12: Indian Pharma Retail Value Chain
  • Exhibit 2.13: Indian Pharma R&D Value-Chain
  • Exhibit 3.1: Urban Population in India (2000-2020)
  • Exhibit 3.2: Net National per Capita Income of India 2011-2015
  • Exhibit 3.3: Top Indian States with highest Urban & Rural IMR per 1000 birth - 2013
  • Exhibit 3.4: Top Ten disease causing death in India (2013-14)
  • Exhibit 4.1.1: Estimated Market size of the Indian Pharma Manufacturing Industry 2015-2020 USD billion
  • Exhibit 4.1.2: Estimated CAGR% of the Indian Pharma Manufacturing Industry 2015-2020
  • Exhibit 4.2.1: Estimated Market Size of the Global Medical Devices & Equipment Industry 2013-2020 in USD billion
  • Exhibit 4.2.2: Estimated Market size of the Indian Medical devices & Equipment Industry 2015-2020 in USD billion
  • Exhibit 4.2.3: Estimated CAGR% of the Indian Medical Device & Equipment Industry 2015-2020
  • Exhibit 4.3.1: Estimated Market size of the Global Medical Transcription Industry 2015-2020
  • Exhibit 4.3.2: Estimated Market size of The Indian Medical Transcription Industry 2015-2020 in USD million
  • Exhibit 4.3.3: Estimated CAGR% of the Indian Medical Transcription Industry 2015-2020
  • Exhibit 4.3.4: Estimated Market size of Indian Private Sector Telemedicine Industry 2015-2020 in USD million
  • Exhibit 4.3.5: Estimated CAGR% of Indian Private Sector Telemedicine Industry 2015-2020
  • Exhibit 4.4.1: Estimated Market size of Global Pharma Packaging 2015-2020 in USD billion
  • Exhibit 4.4.2: Estimated Market size of the Indian Pharma Packaging Industry 2015-2020 in USD billion
  • Exhibit 4.4.3: Estimated CAGR% of Indian Pharma Packaging Industry 2015-2020 in USD billion
  • Exhibit 4.5.1: Forecast for Pharma Retail Industry in India 2015-2020 (in USD bn)
  • Exhibit 4.5.2: Forecast for Pharma Retail Industry in India 2015-2020 (in %)
  • Exhibit 4.5.3: Estimated break-up of the Indian Pharma Industry 2015-2020 in USD billion
  • Exhibit 4.5.4: Estimated break-up of the Indian Pharma Industry 2020
  • Exhibit 5.1: Export Value of Pharmaceutical Products from India (in US$ million) from FY 03-04 to FY 13-14
  • Exhibit 5.2: Export Volume of Pharmaceutical Products from India (in thousands Kg) from FY 03-04 to FY 13-14
  • Exhibit 5.3: Top 5 Nations Importing Indian Pharmaceutical Products (in US$ million) in FY 13-14
  • Exhibit 5.4: Import Value of Pharmaceutical Products in India (in US$ million) from FY 03-04 to FY 13-14
  • Exhibit 5.5: Import Volume of Pharmaceutical Products in India (in thousands Kg) from FY 03-04 to FY 13-14
  • Exhibit 5.6: Top 5 Nations Exporting Pharmaceutical Products to India (in US$ million) in FY 13-14
  • Exhibit 5.7: Export Value of Medical Devices from India (in US$ million) from FY 03-04 to FY 13-14
  • Exhibit 5.8: Export Volume of Medical Devices from India (in thousands) from FY 03-04 to FY 13-14
  • Exhibit 5.9: Top 5 Nations Importing Indian Medical Devices (in US$ million) in FY 13-14
  • Exhibit 5.10: Import Value of Medical Devices in India (in US$ million) from FY 03-04 to FY 13-14
  • Exhibit 5.11: Import Volume of Medical Devices in India (in thousands) from FY 03-04 to FY 13-14
  • Exhibit 5.12: Top 5 Nations Exporting Medical Devices to India (in US$ million) in FY 13-14
  • Exhibit 6.1: Sector-wise Pharmaceuticals Sales 2011-2016 (est) in US$ million
  • Exhibit 6.2: Growth Drivers and Inhibitors for Pharmaceuticals Manufacturing Industry in India
  • Exhibit 6.3: Growth Drivers and Inhibitors for the Medical Device Manufacturing Industry in India
  • Exhibit 6.4: Growth Drivers and Inhibitors for Pharmaceuticals Services Industry in India
  • Exhibit 6.5: Growth Drivers and Inhibitors for Pharmaceuticals Packaging Industry in India
  • Exhibit 6.6: Growth Drivers and Inhibitors for Pharmaceuticals Retail Industry in India
  • Exhibit 6.7: Growth Drivers and Inhibitors for Pharmaceuticals R&D Industry in India
  • Exhibit 7.1: Code for Marketing practices in Indian Pharmaceuticals Industry
  • Exhibit 9.1.1: Key Information of IDMA
  • Exhibit 9.1.2: Contact details of IDMA
  • Exhibit 9.2.1: Key information of IPMMA
  • Exhibit 9.2.2: Contact details of IPMMA
  • Exhibit 9.3.1: Key Information of IPA
  • Exhibit 9.3.2: Contact details of IPA
  • Exhibit 9.4.1: Key information of OPPI
  • Exhibit 9.4.2: Contact details of OPPI
  • Exhibit 9.5.1: Contact information for AIMED
  • Exhibit 11.1.1: Key Information of Abbott India
  • Exhibit 11.1.2: Contact Information of Abbott India
  • Exhibit 11.1.3: Abbott India in Pharma Manufacturing Value chain
  • Exhibit 11.1.4: Abbott India Consolidated Revenue 2009-2014 (in INR billion)
  • Exhibit 11.1.5: Abbott India Growth Rate 2009-2014 (in %)
  • Exhibit 11.1.6: Estimated Year wise Abbott India Revenue 2015-2020 (in INR billion)
  • Exhibit 11.1.7: Estimated Year-wise Abbott India Revenue Growth 2015-2020 (in %)
  • Exhibit 11.1.8: Top performing brands of Abbott India 2014
  • Exhibit 11.1.9: Product Range of Abbott India
  • Exhibit 11.1.10: SWOT Analysis of Abbott India
  • Exhibit 11.2.1: Key Information of Biocon Limited
  • Exhibit 11.2.2: Contact Information of Biocon Limited
  • Exhibit 11.2.3: Biocon Ltd in Pharma Manufacturing Value Chain
  • Exhibit 11.2.4: Biocon Limited Revenue 2010-2014 (in INR billion)
  • Exhibit 11.2.5: Year-wise Biocon Limited Revenue Growth 2010-14 (in %)
  • Exhibit 11.2.6: Category Wise Revenue Breakup for Biocon Limited 2010-14 (in INR billion)
  • Exhibit 11.2.7: Estimated Year wise Biocon Limited Revenue 2015-2020 (in INR billion)
  • Exhibit 11.2.8: Estimated Year-wise Biocon Limited Revenue Growth 2015-2020 (in %)
  • Exhibit 11.2.9: Estimated Category Wise Revenue Breakup for Biocon Limited 2015-20 (in INR billion)
  • Exhibit 11.2.10: Key Products of Biocon Limited
  • Exhibit 11.2.11: Key Services Offered by Biocon Limited
  • Exhibit 11.2.12: SWOT Analysis of Biocon Limited
  • Exhibit 11.3.1: Key Information of Cipla Limited
  • Exhibit 11.3.2: Contact Information of Cipla Limited
  • Exhibit 11.3.3: Cipla Limited in Pharmaceutical Manufacturing Value chain
  • Exhibit 11.3.4: Cipla Limited Revenue 2010-2014 (in INR billion)
  • Exhibit 11.3.5: Year-wise Cipla Limited Revenue Growth 2010-2014 (in %)
  • Exhibit 11.3.6: Cipla Limited Export Revenue 2010-2014 (in INR billion)
  • Exhibit 11.3.7: Year-wise Cipla Limited Export Revenue Growth 2010-2014 (in %)
  • Exhibit 11.3.8: Cipla Limited Domestic Revenue 2010-2014 (in INR billion)
  • Exhibit 11.3.9: Year-wise Cipla Limited Domestic Revenue Growth 2010-2014 (in %)
  • Exhibit 11.3.10: Cipla Limited Product Sales Revenue 2010-2014 (in INR billion)
  • Exhibit 11.3.11: Year-wise Cipla Limited Product Sales Revenue Growth 2010-2014 (in %)
  • Exhibit 11.3.12: Estimated Year wise Cipla Limited Revenue 2015-2020 (in INR billion)
  • Exhibit 11.3.13: Estimated Year-wise Cipla Limited Revenue Growth 2015-2020 (in %)
  • Exhibit 11.3.14: Estimated Cipla Limited Export Revenue 2015-2020 (in INR billion)
  • Exhibit 11.3.15: Estimated Year-wise Cipla Limited Export Revenue Growth 2015-2020 (in %)
  • Exhibit 11.3.16: Estimated Cipla Limited Domestic Revenue 2015-2020 (in INR billion)
  • Exhibit 11.3.17: Estimated Year-wise Cipla Limited Domestic Revenue Growth 2015-2020 (in %)
  • Exhibit 11.3.18: Estimated Cipla Limited Product Sales Revenue 2015-2020 (in INR billion)
  • Exhibit 11.3.19: Estimated Year-wise Cipla Limited Product Sales Revenue Growth 2015-2020 (in %)
  • Exhibit 11.3.20: Key Products of Cipla Limited
  • Exhibit 11.3.21: Key Services of Cipla Limited
  • Exhibit 11.3.22: SWOT Analysis of Cipla Limited
  • Exhibit 11.4.1: Key Information of Dr. Reddy's Laboratories
  • Exhibit 11.4.2: Contact Information of Dr. Reddy's Laboratories
  • Exhibit 11.4.3: Dr. Reddy's Laboratories in Pharmaceuticals Manufacturing Value Chain
  • Exhibit 11.4.4: Dr. Reddy's Laboratories Revenue 2010-2014 (in INR billion)
  • Exhibit 11.4.5: Year-wise Dr. Reddy's Laboratories Revenue Growth 2010-14 (in %)
  • Exhibit 11.4.6: Dr. Reddy's Laboratories Domestic Revenue 2010-2014 (in INR billion)
  • Exhibit 11.4.7: Year-wise Dr. Reddy's Laboratories Domestic Revenue Growth 2010-2014 (in %)
  • Exhibit 11.4.8: Dr. Reddy's Laboratories Export Revenue 2010-2014 (in INR billion)
  • Exhibit 11.4.9: Year-wise Dr. Reddy's Laboratories Export Revenue Growth 2010-2014 (in %)
  • Exhibit 11.4.10: Estimated Year wise Dr. Reddy's Laboratories Revenue 2015-2020 (in INR billion)
  • Exhibit 11.4.11: Estimated Year-wise Dr. Reddy's Laboratories Revenue Growth 2015-2020 (in %)
  • Exhibit 11.4.12: Estimated Dr. Reddy's Laboratories Domestic Revenue 2015-2020 (in INR billion)
  • Exhibit 11.4.13: Estimated Year-wise Dr. Reddy's Laboratories Domestic Revenue Growth 2015-2020 (in %)
  • Exhibit 11.4.14: Estimated Dr. Reddy's Laboratories Export Revenue 2015-2020 (in INR billion)
  • Exhibit 11.4.15: Estimated Year-wise Dr. Reddy's Laboratories Export Revenue Growth 2015-2020 (in %)
  • Exhibit 11.4.16: Key Products of Dr. Reddy's Laboratories
  • Exhibit 11.4.17: Key Services of Dr. Reddy's Laboratories
  • Exhibit 11.4.18: SWOT Analysis of Dr. Reddy's Laboratories
  • Exhibit 11.5.1: Key Information of Sun Pharmaceuticals Limited
  • Exhibit 11.5.2: Contact Information of Sun Pharmaceuticals Limited
  • Exhibit 11.5.3: Sun Pharmaceuticals Limited in Pharma Manufacturing Value Chain
  • Exhibit 11.5.4: Sun Pharmaceuticals Limited Revenue 2010-2014 (in INR billion)
  • Exhibit 11.5.5: Year-wise Sun Pharmaceuticals Limited Revenue Growth 2010-14 (in %)
  • Exhibit 11.5.6: Sun Pharmaceuticals Limited Domestic Revenue 2010-2014 (in INR billion)
  • Exhibit 11.5.7: Year-wise Sun Pharmaceuticals Limited Domestic Revenue Growth 2011-2014 (in %)
  • Exhibit 11.5.8: Sun Pharmaceuticals Limited Export Revenue 2010-2014 (in INR billion)
  • Exhibit 11.5.9: Year-wise Sun Pharmaceuticals Limited Export Revenue Growth 2011-2014 (in %)
  • Exhibit 11.5.10: Estimated Year wise Sun Pharmaceuticals Limited Revenue 2015-2020 (in INR billion)
  • Exhibit 11.5.11: Estimated Year-wise Sun Pharmaceuticals Limited Revenue Growth 2015-2020 (in %)
  • Exhibit 11.5.12: Estimated Sun Pharmaceuticals Limited Domestic Revenue 2015-2020 (in INR billion)
  • Exhibit 11.5.13: Estimated Year-wise Sun Pharmaceuticals Limited Domestic Revenue Growth 2015-2020 (in %)
  • Exhibit 11.5.14: Estimated Sun Pharmaceuticals Limited Export Revenue 2015-2020 (in INR billion)
  • Exhibit 11.5.15: Estimated Year-wise Sun Pharmaceuticals Limited Export Revenue Growth 2015-2020 (in %)
  • Exhibit 11.5.16: Key Products of Sun Pharmaceuticals Limited
  • Exhibit 11.5.17: SWOT Analysis of Sun Pharmaceuticals Limited
  • Exhibit 11.6.1: Key Information of Lupin Limited
  • Exhibit 11.6.2: Contact Information of Lupin Limited
  • Exhibit 11.6.3: Lupin Limited in Pharma Manufacturing Value Chain
  • Exhibit 11.6.4: Lupin Limited Revenue 2010-2014 (in INR billion)
  • Exhibit 11.6.5: Year-wise Lupin Limited Revenue Growth 2010-14 (in %)
  • Exhibit 11.6.6: Lupin Limited Domestic Revenue 2010-2014 (in INR billion)
  • Exhibit 11.6.7: Year-wise Lupin Limited Domestic Revenue Growth 2010-2014 (in %)
  • Exhibit 11.6.8: Lupin Limited Export Revenue 2010-2014 (in INR billion)
  • Exhibit 11.6.9: Year-wise Lupin Limited Export Revenue Growth 2010-2014 (in %)
  • Exhibit 11.6.10: Estimated Year wise Lupin Limited Revenue 2015-2020 (in INR billion)
  • Exhibit 11.6.11: Estimated Year-wise Lupin Limited Revenue Growth 2015-2020 (in %)
  • Exhibit 11.6.12: Estimated Lupin Limited Domestic Revenue 2015-2020 (in INR billion)
  • Exhibit 11.6.13: Estimated Year-wise Lupin Limited Domestic Revenue Growth 2015-2020 (in %)
  • Exhibit 11.6.14: Estimated Lupin Limited Export Revenue 2015-2020 (in INR billion)
  • Exhibit 11.6.15: Estimated Year-wise Lupin Limited Export Revenue Growth 2015-2020 (in %)
  • Exhibit 11.6.17: Key Products of Lupin Limited
  • Exhibit 11.6.17: SWOT Analysis of Lupin Limited
  • Exhibit 11.7.1: Key Information of Aurobindo Pharma Limited
  • Exhibit 11.7.2: Contact Information of Aurobindo Pharma Limited
  • Exhibit 11.7.3: Aurobindo Pharma Limited in Pharma Manufacturing Value Chain
  • Exhibit 11.7.4: Aurobindo Pharma Limited Revenue 2010-2014 (in INR billion)
  • Exhibit 11.7.5: Year-wise Aurobindo Pharma Limited Revenue Growth 2010-14 (in %)
  • Exhibit 11.7.6: Estimated Year wise Aurobindo Pharma Limited Revenue 2015-2020 (in INR billion)
  • Exhibit 11.7.7: Estimated Year-wise Aurobindo Pharma Limited Revenue Growth 2015-2020 (in %)
  • Exhibit 11.7.8: SWOT Analysis of Aurobindo Pharmaceuticals
  • Exhibit 11.8.1: Key Information of Torrent Pharmaceuticals Limited
  • Exhibit 11.8.2: Contact Information of Torrent Pharmaceuticals Limited
  • Exhibit 11.8.3: Torrent Pharmaceuticals Limited in Pharma Manufacturing Value Chain
  • Exhibit 11.8.4: Torrent Pharmaceuticals Limited Revenue 2010-2014 (in INR billion)
  • Exhibit 11.8.5: Year-wise Torrent Pharmaceuticals Limited Revenue Growth 2010-14 (in %)
  • Exhibit 11.8.6: Estimated Year wise Torrent Pharmaceuticals Limited Revenue 2015-2020 (in INR billion)
  • Exhibit 11.8.7: Estimated Year-wise Torrent Pharmaceuticals Limited Revenue Growth 2015-2020 (in %)
  • Exhibit 11.8.8: Key Products of Torrent Pharmaceuticals Limited
  • Exhibit 11.8.9: SWOT Analysis of Torrent Pharmaceuticals Limited
  • Exhibit 11.9.1: Key Information of Divis Laboratories Limited
  • Exhibit 11.9.2: Contact Information of Divis Laboratories Limited
  • Exhibit 11.9.3: Divis Laboratories Limited in Pharma Manufacturing Value Chain
  • Exhibit 11.9.4: Divis Laboratories Limited Revenue 2010-2014 (in INR billion)
  • Exhibit 11.9.5: Year-wise Divis Laboratories Limited Revenue Growth 2010-14 (in %)
  • Exhibit 11.9.6: Divis Laboratories Limited Domestic Revenue 2010-2014 (in INR billion)
  • Exhibit 11.9.7: Year-wise Divis Laboratories Limited Domestic Revenue Growth 2010-2014 (in %)
  • Exhibit 11.9.8: Divis Laboratories Limited Export Revenue 2010-2014 (in INR billion)
  • Exhibit 11.9.9: Year-wise Divis Laboratories Limited Export Revenue Growth 2010-2014 (in %)
  • Exhibit 11.9.10: Estimated Year wise Divis Laboratories Limited Revenue 2015-2020 (in INR billion)
  • Exhibit 11.9.11: Estimated Year-wise Divis Laboratories Limited Revenue Growth 2015-2020 (in %)
  • Exhibit 11.9.12: Estimated Divis Laboratories Limited Domestic Revenue 2015-2020 (in INR billion)
  • Exhibit 11.9.13: Estimated Year-wise Divis Laboratories Limited Domestic Revenue Growth 2015-2020 (in %)
  • Exhibit 11.9.14: Estimated Divis Laboratories Limited Export Revenue 2015-2020 (in INR billion)
  • Exhibit 11.9.15: Estimated Year-wise Divis Laboratories Limited Export Revenue Growth 2015-2020 (in %)
  • Exhibit 11.9.16: Key Products of Divis Laboratories Limited
  • Exhibit 11.9.17: SWOT Analysis of Divis Laboratories Limited
  • Exhibit 11.10.1: Key Information of Ipca Laboratories Limited
  • Exhibit 11.10.2: Contact details of Ipca Laboratories Limited
  • Exhibit 11.10.3: IPCA Laboratories Limited in Pharma Manufacturing Value Chain
  • Exhibit 11.10.4: IPCA Laboratories Limited Revenue 2010-2014 (in INR billion)
  • Exhibit 11.10.5: Year-wise IPCA Laboratories Limited Revenue Growth 2010-2014 (in %)
  • Exhibit 11.10.6: Estimated Year wise IPCA Laboratories Limited Revenue 2015-2020 (in INR billion)
  • Exhibit 11.10.7: Estimated Year-wise IPCA Laboratories Limited Revenue Growth 2015-2020 (in %)
  • Exhibit 11.10.8: IPCA Laboratories Limited Revenue by Geography 2014 (in INR billion)
  • Exhibit 11.1.10.9: Export and domestic revenue of IPCA Laboratories Limited
  • Exhibit 11.10.10: IPCA Laboratories Limited Sales Break-up 2014 (in INR billion)
  • Exhibit 11.10.11: Key Products of IPCA Laboratories Limited
  • Exhibit 11.10.12: Key Services of IPCA Laboratories Limited
  • Exhibit 11.10.13: SWOT Analysis of IPCA Laboratories Limited
  • Exhibit 11.10.14: Key Customers of IPCA Laboratories Limited
  • Exhibit 11.11.1: Key Information of Beacton Dickinson & Company Limited
  • Exhibit 11.11.2: Contact Information of Beacton Dickinson & Company Limited
  • Exhibit 11.11.3: Beacton Dickinson & Company Limited in Pharma Manufacturing Value Chain
  • Exhibit 11.11.4: Beacton Dickinson & Company Limited Revenue 2011-2014 (in INR billion)
  • Exhibit 11.11.5: Year-wise Beacton Dickinson & Company Limited Revenue Growth 2012-14 (in %)
  • Exhibit 11.11.6: Beacton Dickinson & Company Limited Revenue from India 2011-2014 (in INR billion)
  • Exhibit 11.11.7: Year-wise Beacton Dickinson & Company Limited Revenue from India Growth 2012-2014 (in %)
  • Exhibit 11.11.8: Estimated Year wise Beacton Dickinson & Company Limited Revenue 2015-2020 (in INR billion)
  • Exhibit 11.11.9: Estimated Year-wise Beacton Dickinson & Company Limited Revenue Growth 2015-2020 (in %)
  • Exhibit 11.11.10: Estimated Beacton Dickinson & Company Limited Revenue from India 2015-2020 (in INR billion)
  • Exhibit 11.11.11: Estimated Year-wise Beacton Dickinson & Company Limited Revenue from India Growth 2012-2014 (in %)
  • Exhibit 11.11.12: SWOT Analysis of Beacton Dickinson & Company Limited
  • Exhibit 11.12.1: Key Information of Poly Medicure Limited
  • Exhibit 11.12.2: Contact Information of Poly Medicure Limited
  • Exhibit 11.12.3: Poly Medicure Limited in Medical Devices Manufacturing Value Chain
  • Exhibit 11.12.4: Poly Medicure Limited Revenue 2010-2014 (in INR billion)
  • Exhibit 11.12.5: Year-wise Poly Medicure Limited Revenue Growth 2011-14 (in %)
  • Exhibit 11.12.6: Poly Medicure Limited Product Sales Revenue from India 2011-2014 (in INR billion)
  • Exhibit 11.12.7: Year-wise Poly Medicure Limited Product Sales Revenue from India 2012-2014 (in %)
  • Exhibit 11.12.8: Poly Medicure Limited Export Revenue 2011-2014 (in INR billion)
  • Exhibit 11.12.9: Poly Medicure Limited Domestic Revenue 2011-2014 (in INR billion)
  • Exhibit 11.12.10: Estimated Year wise Poly Medicure Limited Revenue 2015-2020 (in INR billion)
  • Exhibit 11.12.11: Estimated Year-wise Poly Medicure Limited Revenue Growth 2015-2020 (in %)
  • Exhibit 11.12.12: Estimated Poly Medicure Limited Product Sales Revenue 2015-2020 (in INR billion)
  • Exhibit 11.12.13: Estimated Year-wise Poly Medicure Limited Product Sales Revenue Growth 2015-2020 (in %)
  • Exhibit 11.12.14: Estimated Poly Medicure Limited Export Revenue 2015-2020 (in INR billion)
  • Exhibit 11.12.15: Estimated Poly Medicure Limited Domestic Revenue 2015-2020 (in INR billion)
  • Exhibit 11.12.16: Key Products of Poly Medicure Limited
  • Exhibit 11.12.17: SWOT Analysis of Polymedicure India Limited
  • Exhibit 11.13.1: Key Information of Novartis India Limited
  • Exhibit 11.13.2: Contact Information of Novartis India Limited
  • Exhibit 11.13.3: Novartis India Limited in Medical Devices Manufacturing Value Chain
  • Exhibit 11.13.4: Novartis India Limited Revenue 2011-2014 (in INR billion)
  • Exhibit 11.13.5: Year-wise Novartis India Limited Revenue Growth 2012-14 (in %)
  • Exhibit 11.13.6: Novartis India Limited Domestic Revenue 2011-2014 (in INR billion)
  • Exhibit 11.13.7: Year-wise Novartis India Limited Domestic Revenue Growth 2012-2014 (in %)
  • Exhibit 11.13.8: Novartis India Limited Product Sales Revenue 2010-2014 (in INR billion)
  • Exhibit 11.13.9: Year-wise Novartis India Limited Product Sales Revenue Growth 2010-2014 (in %)
  • Exhibit 11.13.10: Estimated Year wise Novartis India Limited Revenue 2015-2020 (in INR billion)
  • Exhibit 11.13.11: Estimated Year-wise Novartis India Limited Revenue Growth 2015-2020 (in %)
  • Exhibit 11.13.12: Estimated Novartis India Limited Domestic Revenue 2015-2020 (in INR billion)
  • Exhibit 11.13.13: Estimated Year-wise Novartis India Limited Domestic Revenue Growth 2015-2020 (in %)
  • Exhibit 11.13.14: Estimated Novartis India Limited Product Sales Revenue 2015-2020 (in INR billion)
  • Exhibit 11.13.15: Estimated Year-wise Novartis India Limited Product Sales Revenue Growth 2015-2020 (in %)
  • Exhibit 11.13.16: SWOT Analysis of Novartis India Limited
  • Exhibit 11.14.1: Key Information of Apollo Pharmacy
  • Exhibit 11.14.2: Contact Information of Apollo Pharmacy
  • Exhibit 11.14.3: Apollo Pharmacy in Pharma Retail Value Chain
  • Exhibit 11.14.4: SWOT Analysis of Apollo Pharmacy
  • Exhibit 11.15.1: Key Information of MedPlus Health Services Pvt. Ltd.
  • Exhibit 11.15.2: Contact Information of MedPlus Health Services Pvt. Ltd.
  • Exhibit 11.15.3: MedPlus Health Services Pvt. Ltd. in Pharma Retail Value Chain
  • Exhibit 11.15.4: SWOT Analysis of MedPlus Health Services Pvt. Ltd.
  • Exhibit 11.16.1: Key Information & Contact details of NIPER Campuses
  • Exhibit 11.16.2: NIPER in Pharma Research and Development Value Chain
  • Exhibit 11.16.3: NIPER Mohali in Pharma Research and Development Value Chain
  • Exhibit 11.16.4: Central Government Budget for individual NIPER (in INR million)
  • Exhibit 11.16.5: Publications Launched by Different NIPER Centers 2008-2014
  • Exhibit 11.16.6: Publications Contribution by Different NIPER Centers 2008-2014
  • Exhibit 11.16.7: Number of Scientific Publications Launched by NIPER Mohali 2008-2013
  • Exhibit 11.16.8: Number of Scientific Publications Launched by NIPER Ahmedabad 2008-2013
  • Exhibit 11.16.9: Number of Scientific Publications Launched by NIPER Hyderabad 2009-2014
  • Exhibit 11.16.10: SWOT Analysis of National Institute of Pharmaceutical Education and Research (NIPER)
  • Exhibit 12.1: Revenues of few Key Pharma Companies
  • Exhibit 12.2: Top Pharmaceutical Company by Net Sales
  • Exhibit 12.3: Market Size of Indian Pharmaceutical Industry 2014 (USD billion)
  • Exhibit 12.4: Break Up of Indian Pharma Industry 2014
  • Exhibit 12.5: Indian Medical Devices & Equipment Industry 2010-2014 (in USD billion)
  • Exhibit 12.6: Indian Private Sector Telemedicine Market 2011-2014 (in USD million)
  • Exhibit 12.7: Global Pharma Packaging Industry 2010-2014 (USD billion)
  • Exhibit 12.8: Indian Pharma Packaging Market Size 2009-2014 (in USD billion)
  • Exhibit 12.9: Domestic Pharma Sales Break-up in India 2014
  • Exhibit 12.10: Indian Pharmaceutical Sales 2012-14 (USD billion)
  • Exhibit 13.1: PESTEL Analysis of the Indian Pharma Industry
  • Exhibit 13.2: SWOT Analysis of the Indian Pharma Industry
  • Exhibit 13.3: Porter's Five Forces Analysis of Pharmaceuticals Industry in India
  • Exhibit 13.4: SWOT Analysis of Indian Pharmaceuticals Manufacturing Industry
  • Exhibit 13.5: Porter's Five Forces Analysis of Indian Pharmaceuticals Manufacturing Industry
  • Exhibit 13.6: SWOT Analysis of Indian Medical Device Manufacturing Industry
  • Exhibit 13.7: Porter's Five Forces Analysis of Indian Medical Device Manufacturing Industry
  • Exhibit 13.8: SWOT Analysis of Indian Pharmaceuticals Services Industry
  • Exhibit 13.9: Porter's Five Forces Analysis of Indian Pharmaceuticals Services Industry
  • Exhibit 13.10: SWOT Analysis of Indian Pharmaceuticals Packaging Industry
  • Exhibit 13.11: Porter's Five Forces Analysis of Indian Pharmaceuticals Packaging Industry
  • Exhibit 13.12: SWOT Analysis of Indian Pharmaceuticals Retail Industry
  • Exhibit 13.13: Porter's Five Forces Analysis of Indian Pharmaceuticals Retail Industry
  • Exhibit 13.14: SWOT Analysis of Indian Pharmaceuticals R&D Industry
  • Exhibit 13.15: Porter's Five Forces Analysis of Indian Pharmaceuticals R&D Industry
Back to Top